Yakira Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Yakira Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,705	Closed	-$4K	–	444
2022 Q1	$4K	Hold	11,705	–	–	﹤0.01%	452
2021 Q4	$17K	Sell	11,705 -11,295	-49%	-$15.7K	﹤0.01%	406
2021 Q3	$34K	Sell	23,000 -2,500	-10%	-$2.67K	0.01%	356
2021 Q2	$29K	Sell	25,500 -12,266	-32%	-$11.6K	﹤0.01%	370
2021 Q1	$31K	Sell	37,766 -3,900	-9%	-$5.7K	0.01%	342
2020 Q4	$60K	Hold	41,666	–	–	0.01%	244
2020 Q3	$49K	Buy	+41,666	New	+$42.1K	0.01%	220

Other funds holding JSPRW

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Yakira Capital Management's JSPRW Position: Q2 2022 in Review

Yakira Capital Management sold out of Japer Therapeutics Warrants (JSPRW) in Q2 2022, closing a stake of 11,705 shares — an estimated $4K sold.

Yakira Capital Management first reported a position in JSPRW in Q3 2020 and held it in 7 quarters. The position peaked at $60K in Q4 2020. 14 funds tracked by Wall St. Rank hold JSPRW as of Q2 2022.

Yakira Capital Management reported no remaining Japer Therapeutics Warrants position as of Q2 2022 after selling out during the quarter.
Yakira Capital Management sold 11,705 Japer Therapeutics Warrants shares in Q2 2022, an estimated $4K.
Yakira Capital Management first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 7 quarters.
Yakira Capital Management's Japer Therapeutics Warrants position peaked at $60K in Q4 2020.
14 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2022.

Based on Yakira Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.